Influence of the target vessel on the location and area of maximum skin dose during percutaneous coronary intervention.

BACKGROUND

A number of cases involving radiation-associated patient skin injury attributable to percutaneous coronary intervention (PCI) have been reported. Knowledge of the location and area of the patient's maximum skin dose (MSD) in PCI is necessary to reduce the risk of skin injury.

PURPOSE

To determine the location and area of the MSD in PCI, and separately analyze the effects of different target vessels.

MATERIAL AND METHODS

197 consecutive PCI procedures were studied, and the location and area of the MSD were calculated by a skin-dose mapping software program: Caregraph. The target vessels of the PCI procedures were divided into four groups based on the American Heart Association (AHA) classification.

RESULTS

The sites of the MSD for AHA #1-3, AHA #4, and AHA #11-15 were located mainly on the right back skin, the lower right or center back skin, and the upper back skin areas, respectively, whereas the MSD sites for the AHA #5-10 PCI were widely spread. The MSD area for the AHA #4 PCI was larger than that for the AHA #11-15 PCI (P<0.0001).

CONCLUSION

Although the radiation associated with PCI can be widely spread and variable, we observed a tendency regarding the location and area of the MSD when we separately analyzed the data for different target vessels. We recommend the use of a smaller radiation field size and the elimination of overlapping fields during PCI.